Publications scientifiques

Téléchargez nos documents

2014 Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival: Genome Research

2013 Erlotinib versus docetaxel as second-line treatment of patients with advanced NSCLC and wild-type EGFR tumours

2013 Increase in CD14+HLA-DR2/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis: Cancer Immunology-Immunotherapy

2013 Clinical Impact of Immune Microenvironment in Stage I Lung Adenocarcinoma

2012 The Transcription Factor T-bet Regulates Intestinal Inflammation Mediated by Interleukin-7 Receptor+ Innate Lymphoid Cells: Immunity

2012 Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study: Journal of Clinical Oncology

2012 Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, NSCLC with poor prognosis

2010 Inducing CTLA-4-dependent Immune Regulation by Selective CD28 blockade Promotes Regulatory T cells in Organ Transplantation: Science Transl Med

2003 Mucosal T cells Expressing High Levels of IL-7 Receptor Are potentail Targets for Treatment of Chronic Colitis: Journal of Immunology

1 2 3 4 5